Literature DB >> 23127729

Clostridium difficile: the emerging epidemic.

Nasia Safdar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23127729      PMCID： PMC3532692          DOI： 10.1016/j.mayocp.2012.09.004

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  15 in total

1.  Proton pump inhibitors and risk for recurrent Clostridium difficile infection.

Authors:  Amy Linsky; Kalpana Gupta; Elizabeth V Lawler; Jennifer R Fonda; John A Hermos
Journal:  Arch Intern Med       Date:  2010-05-10

Review 2.  Treatment of Clostridium difficile-associated disease: old therapies and new strategies.

Authors:  Saima Aslam; Richard J Hamill; Daniel M Musher
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

Review 3.  Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review.

Authors:  Tim Planche; Adamma Aghaizu; Richard Holliman; Peter Riley; Jan Poloniecki; Aodhán Breathnach; Sanjeev Krishna
Journal:  Lancet Infect Dis       Date:  2008-11-01       Impact factor: 25.071

Review 4.  Clostridium difficile infection: new insights into management.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

5.  Risk factors for early recurrent Clostridium difficile-associated diarrhea.

Authors:  A N Do; S K Fridkin; A Yechouron; S N Banerjee; G E Killgore; A M Bourgault; M Jolivet; W R Jarvis
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

6.  Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study.

Authors:  Donna O Lowe; Muhammad M Mamdani; Alexander Kopp; Donald E Low; David N Juurlink
Journal:  Clin Infect Dis       Date:  2006-10-13       Impact factor: 9.079

7.  Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools.

Authors:  Manfred Hauben; Sebastian Horn; Lester Reich; Muhammad Younus
Journal:  Int J Infect Dis       Date:  2007-03-02       Impact factor: 3.623

8.  Treatment with monoclonal antibodies against Clostridium difficile toxins.

Authors:  Israel Lowy; Deborah C Molrine; Brett A Leav; Barbra M Blair; Roger Baxter; Dale N Gerding; Geoffrey Nichol; William D Thomas; Mark Leney; Susan Sloan; Catherine A Hay; Donna M Ambrosino
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

9.  Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.

Authors:  Mohammed Aseeri; Todd Schroeder; Joan Kramer; Rosalee Zackula
Journal:  Am J Gastroenterol       Date:  2008-08-12       Impact factor: 10.864

10.  Clostridium difficile infection in patients with chronic kidney disease.

Authors:  Mira T Keddis; Sahil Khanna; Amit Noheria; Larry M Baddour; Darrell S Pardi; Qi Qian
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616
View more
  1 in total

1.  Effect of United States buckwheat honey on antibiotic-resistant hospital acquired pathogens.

Authors:  Eric Nee-Armah Hammond; Megan Duster; Jackson Ssentalo Musuuza; Nasia Safdar
Journal:  Pan Afr Med J       Date:  2016-12-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.